The mRNA therapeutics and vaccines market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors.   This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile...